Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliott Vichinsky

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|June 16, 2021
Time to rethink haemoglobin threshold guidelines in sickle cell diseaseSamir K Ballas, Frans A Kuypers, Victor R Gordeuk, et al.
Journal of Pediatric Hematology/Oncology|April 25, 2002
Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP)Beatrice Files, Don Brambilla, Abdullah Kutlar, et al.
American Journal of Clinical Pathology|March 15, 2005
Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosisEllen Butensky, Roland Fischer, Mark Hudes, et al.
Blood|November 15, 2003
Gene interactions and stroke risk in children with sickle cell anemiaCarolyn Hoppe, William Klitz, Suzanne Cheng, et al.
Pediatric Blood & Cancer|September 2, 2014
Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)Susan T Paulukonis, William T Harris, Thomas D Coates, et al.
Pediatric Hematology and Oncology|July 20, 2006
Prevalence of HFE mutations in California newbornsCarolyn Hoppe, Robert M Watson, Christopher M Long, et al.
Blood Cells, Molecules & Diseases|November 16, 2012
Combined chelation therapy with deferasirox and deferoxamine in thalassemiaAshutosh Lal, John Porter, Nancy Sweeters, et al.
Pediatric Blood & Cancer|December 17, 2004
Barriers to adherence of deferoxamine usage in sickle cell diseaseMarsha J Treadwell, Amy W Law, Jennifer Sung, et al.
Pediatric Blood & Cancer|April 20, 2006
Caregiving time in sickle cell disease: psychological effects in maternal caregiversJudith Tedlie Moskowitz, Ellen Butensky, Paul Harmatz, et al.
Prenatal Diagnosis|November 19, 2016
Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literatureEmily M Kreger, Sylvia T Singer, Russell G Witt, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|June 16, 2021
Time to rethink haemoglobin threshold guidelines in sickle cell diseaseSamir K Ballas, Frans A Kuypers, Victor R Gordeuk, et al.
Journal of Pediatric Hematology/Oncology|April 25, 2002
Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP)Beatrice Files, Don Brambilla, Abdullah Kutlar, et al.
American Journal of Clinical Pathology|March 15, 2005
Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosisEllen Butensky, Roland Fischer, Mark Hudes, et al.
Blood|November 15, 2003
Gene interactions and stroke risk in children with sickle cell anemiaCarolyn Hoppe, William Klitz, Suzanne Cheng, et al.
Pediatric Blood & Cancer|September 2, 2014
Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)Susan T Paulukonis, William T Harris, Thomas D Coates, et al.
Pediatric Hematology and Oncology|July 20, 2006
Prevalence of HFE mutations in California newbornsCarolyn Hoppe, Robert M Watson, Christopher M Long, et al.
Blood Cells, Molecules & Diseases|November 16, 2012
Combined chelation therapy with deferasirox and deferoxamine in thalassemiaAshutosh Lal, John Porter, Nancy Sweeters, et al.
Pediatric Blood & Cancer|December 17, 2004
Barriers to adherence of deferoxamine usage in sickle cell diseaseMarsha J Treadwell, Amy W Law, Jennifer Sung, et al.
Pediatric Blood & Cancer|April 20, 2006
Caregiving time in sickle cell disease: psychological effects in maternal caregiversJudith Tedlie Moskowitz, Ellen Butensky, Paul Harmatz, et al.
Prenatal Diagnosis|November 19, 2016
Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literatureEmily M Kreger, Sylvia T Singer, Russell G Witt, et al.
Pageof 14